Rhonda Hickman, NP
Adult Health · Tupelo, MSNPI 1992177463
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.2% of the total across 694 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 694 payments — averaging $21.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$2K
- Inspire Medical Systems, Inc.$2K
- Boehringer Ingelheim$1K
- ANI Pharmaceuticals, Inc.$846
- Mallinckrodt Hospital Products Inc.$780
- plus $6K from 28 others
What the payments were for
- Travel & lodging$8736%
- Food & beverage$13,96693%
- Education$1441%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 162 | $2,130 |
| AstraZeneca | 78 | $2,042 |
| Inspire Medical Systems, Inc. | 33 | $2,006 |
| Boehringer Ingelheim | 69 | $1,156 |
| ANI Pharmaceuticals, Inc. | 14 | $846 |
| Mallinckrodt Hospital Products Inc. | 38 | $780 |
| Harmony Biosciences LLC | 28 | $716 |
| Insmed, Inc. | 25 | $688 |
| Jazz Pharmaceuticals Inc. | 24 | $551 |
| Sanofi | 26 | $526 |
| Merck | 23 | $447 |
| Regeneron Healthcare Solutions, Inc. | 20 | $441 |
| Novartis | 21 | $345 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $304 |
| Genentech USA, Inc. | 19 | $294 |
| Mylan Specialty L.p. | 14 | $239 |
| United Therapeutics Corporation | 12 | $207 |
| Bayer | 12 | $204 |
| Electromed, Inc. | 13 | $203 |
| Amgen | 10 | $167 |
| Pulmonx Corporation | 4 | $92 |
| Verona Pharma, Inc. | 4 | $83 |
| Grifols USA, LLC | 3 | $73 |
| La Jolla Pharmaceutical Company | 5 | $71 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| Viatris Specialty LLC | 3 | $65 |
| Baxter Healthcare | 3 | $51 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
| Philips North America LLC | 2 | $35 |
| Pfizer | 2 | $34 |
| Shionogi Inc | 1 | $24 |
| Fisher & Paykel Healthcare Inc | 1 | $21 |
| Ambu Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$992
- FASENRA$798
- BREZTRI$798
- AIRSUPRA$679
- TEZSPIRE$482
- PURIFIED CORTROPHIN GEL$482
- ANDEXXA$308
- TRELEGY ELLIPTA$125
- FARXIGA$119
- ACTHAR$102
How this compares
$14,983 in reported general payments places this provider in the 95th percentile of 93 adult health providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 30 | $373,577 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 302 | $228,693 |
| Breo ElliptaFluticasone/Vilanterol | 145 | $63,077 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 105 | $50,072 |
| NucalaMepolizumab | 13 | $47,214 |
| Spiriva RespimatTiotropium Bromide | 50 | $25,892 |
| SymbicortBudesonide/Formoterol Fumarate | 56 | $15,575 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $14,980 |
| Incruse ElliptaUmeclidinium Bromide | 30 | $11,857 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 20 | $10,723 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 338 | $10,502 |
| BreynaBudesonide/Formoterol Fumarate | 42 | $6,440 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 13 | $6,335 |
| Ventolin HfaAlbuterol Sulfate | 91 | $5,608 |
| Advair HfaFluticasone Propion/Salmeterol | 14 | $4,929 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat | $1,156 | $410,192100 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Nucala, Incruse Ellipta | $2,130 | $400,913595 claims |
| AstraZenecaSymbicort, Breztri Aerosphere, Bevespi Aerosphere | $2,042 | $36,89092 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 93 adult health providers in Mississippi.
Other adult health in Tupelo
- Jessica ChildsTupelo$2K
- Toni BurnettTupelo$2K
- Stephanie GloverTupelo$2K
- Michelle TurbaTupelo$609
- Vivian RogersTupelo$524
- Amanda GreeneRidgeland$108K
- Angela SlaterFlorence$14K
- Jennifer Delaney-DavisOcean Springs$9K
- Traci EvansGulfport$8K
- Casey AdamsGulfport$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.